Cathy Cutler, director of the Medical Isotope Research and Production program at Brookhaven National Laboratory, was honored for her scientific accomplishments at Brookhaven Town's 33rd annual Women's Recognition Night, held in March. She was among 13 women honored for their contributions to a variety of fields at a public ceremony that celebrates the significant achievements of local women during Women's History Month. At Brookhaven Lab, Cutler and her team collaborate on research with radiopharmaceuticals for cancer therapy, and they make radioisotopes required for this research as well. Radiopharmaceuticals are vital for noninvasive, personalized cancer treatments that provide patients with high-impact doses to combat tumors without damaging nearby healthy cells. With more than 20 years' experience developing and evaluating radiopharmaceuticals, Cutler is helping lead their development for "theranostics" that combine medical therapies with diagnostic medical tests. Cutler joined Brookhaven Lab in 2015 after earning a Ph.D. in inorganic chemistry from the University of Cincinnati and spending nearly 17 years at the University of Missouri Research Reactor Center. She serves as a mentor to young scientists, has received numerous awards, and holds several patents. In addition to her role at the Lab, Cutler has served as chair of the Society of Nuclear Medicine and Molecular Imaging's committee on radiopharmaceuticals. She is a board member for the society's Therapy Center of Excellence and Center for Molecular Imaging Innovation and Translation and an executive board member for the Society of Radiopharmaceutical Sciences.